Skip to main content

Peer Review reports

From: The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo

Original Submission
7 Feb 2020 Submitted Original manuscript
6 Aug 2020 Author responded Author comments - Martha Martinez Grimes
27 Feb 2020 Reviewed Reviewer Report - Kun Zhou
29 Jun 2020 Reviewed Reviewer Report
Resubmission - Version 2
6 Aug 2020 Submitted Manuscript version 2
30 Nov 2020 Reviewed Reviewer Report - Research Square Reviewer 2
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
8 Dec 2020 Editorially accepted
7 Jan 2021 Article published 10.1186/s12885-020-07716-1

You can find further information about peer review here.

Back to article page